| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/10/2003 | CA2462162A1 Identification of new cd8 epitopes from hiv-1 proteins with therapeuticaal and vaccinal properties against hiv infections |
| 04/10/2003 | CA2462142A1 Benzisothiazolyl-substituted aminomethyl chromanes for treating diseases of the central nervous system |
| 04/10/2003 | CA2462112A1 Spiro-hydantoin compounds useful as anti-inflammatory agents |
| 04/10/2003 | CA2462110E Phenyl-piperazine derivatives as serotonin reuptake inhibitors |
| 04/10/2003 | CA2462075A1 Estrogen/gestagen combination preparation and application thereof |
| 04/10/2003 | CA2462030A1 3-`hydroxy-(-4-trifluoromethylphenyl)-methyl-7-spirocyclobutyl-5,6,7,8-tetrahydroquinolin-5-ol derivatives and the use of the same as cholesterol ester transfer protein (cetp) inhibitors |
| 04/10/2003 | CA2462023A1 Preparation of levofloxacin and forms thereof |
| 04/10/2003 | CA2462004A1 Systems, methods and apparatuses for manufacturing dosage forms |
| 04/10/2003 | CA2461998A1 Isolated nucleic acid molecules encoding a bacterial uracil transport protein and a bacterial uracil phosphoribosyl-transferase enzyme, cells transformed therewith and uses thereof |
| 04/10/2003 | CA2461919A1 Substituted 2,5-diamidoindoles as ece inhibitors for the treatment of cardiovascular diseases |
| 04/10/2003 | CA2461895A1 Use of mannosamine derivatives for the stimulation of neurite growth |
| 04/10/2003 | CA2461877A1 Method of treatment using ligand-immunogen conjugates |
| 04/10/2003 | CA2461723A1 A method of simultaneously treating sensory auditory gating deficit and associated psychosis in schizophrenia and bipolar disorder patients with mania |
| 04/10/2003 | CA2461686A1 Preparation of an anhydrous quinoline-based cetp inhibitor by crystallization |
| 04/10/2003 | CA2461670A1 Indole derivatives as cox ii inhibitors |
| 04/10/2003 | CA2461618A1 Ibuprofen salt emulsifiers and cream formulations containing same |
| 04/10/2003 | CA2461596A1 Method for treating hepatitis c virus infection in treatment failure patients |
| 04/10/2003 | CA2461586A1 Compounds for the reduction of excessive food intake |
| 04/10/2003 | CA2461560A1 Inhibition of neonatal hyperbilirubinemia in breast fed infants |
| 04/10/2003 | CA2461381A1 Chroman derivatives as 5-hydroxytryptamine-6 ligands |
| 04/10/2003 | CA2461213A1 Process for the preparation of citalopram |
| 04/10/2003 | CA2461197A1 Inhibition of exoproteins using isoprenoids |
| 04/10/2003 | CA2461099A1 Diagnostic or therapeutic somatostatin or bombesin analog conjugates and uses thereof |
| 04/10/2003 | CA2461034A1 Tetrahydroisochinolines, their production and the use thereof as analgesics |
| 04/10/2003 | CA2460916A1 Methods and compositions for modulating interleukin-21 receptor activity |
| 04/10/2003 | CA2460909A1 N-(4-(4-methylthiazol-5-yl) pyrimidin-2-yl) -n-phenylamines as antiproliferative compounds |
| 04/10/2003 | CA2460594A1 Mch receptor antagonists |
| 04/10/2003 | CA2460589A1 Method for treating hepatitis c virus infection in treatment failure patients |
| 04/10/2003 | CA2460486A1 Pseudopolymorphic forms of carvedilol |
| 04/10/2003 | CA2460261A1 Methods for diagnosing and treating diseases and conditions of the heart or digestive system, and cancer |
| 04/10/2003 | CA2460168A1 4¬piperidin-4-yliden-(3-carbamoylphenyl)methyl| benzamide derivatives and their use for the treatment of pain, spinal injuries or gastrointestinal disorders |
| 04/10/2003 | CA2460167A1 Aqueous ecabet sodium solution preparation |
| 04/10/2003 | CA2460006A1 Methods and compositions for treating or preventing bacterial infection |
| 04/10/2003 | CA2459868A1 Preparation of hiv protease inhibitors |
| 04/10/2003 | CA2459825A1 Compounds useful as reversible inhibitors of cysteine proteases |
| 04/10/2003 | CA2459194A1 Method for predicting the sensitivity to chemotherapy |
| 04/10/2003 | CA2458343A1 Pharmaceutical combinations of pde-v inhibitors and other agents |
| 04/10/2003 | CA2457798A1 Process for preparing heterocyclo-alkylsulfonyl pyrazole derivatives |
| 04/10/2003 | CA2457762A1 Antioxidant combination composition and use thereof |
| 04/10/2003 | CA2457647A1 Benzimidazolidinone derivatives as muscarinic agents |
| 04/10/2003 | CA2453343A1 Tetracyclic indole derivatives as 5-ht receptor ligands |
| 04/10/2003 | CA2430328A1 Receptor antagonist |
| 04/09/2003 | EP1300464A1 Fungal cell wall synthesis gene |
| 04/09/2003 | EP1300424A1 Highly cross-linked, extremely hydrophobic nitric oxide-releasing polymers and methods for their manufacture and use |
| 04/09/2003 | EP1300419A1 Antibody of human origin for inhibiting thrombocyte aggregation |
| 04/09/2003 | EP1300412A1 Hyaluronic acid oligosaccharide fractions and drugs containing the same |
| 04/09/2003 | EP1300408A1 Antibacterial substituted 7-acylamino-3-(methylhydrazono)methyl-cephalosporins and intermediates |
| 04/09/2003 | EP1300407A1 Carbamates derived from arylalkylamines |
| 04/09/2003 | EP1300405A1 Amino alcohol derivatives |
| 04/09/2003 | EP1300404A1 Obesity inhibitory materials |
| 04/09/2003 | EP1300399A1 Phenylpyridazine derivatives and drugs containing the same |
| 04/09/2003 | EP1300398A1 Propane-1,3-dione derivatives |
| 04/09/2003 | EP1300394A1 Method for the production of a water-dispersible formulation containing carotenoids |
| 04/09/2003 | EP1300166A1 Means for treatment of coronary artery obstructions |
| 04/09/2003 | EP1300160A1 Method of stabilizing preparation |
| 04/09/2003 | EP1300159A1 Remedies for cancer |
| 04/09/2003 | EP1300158A1 Medicinal compositions for angiogenic therapy |
| 04/09/2003 | EP1300153A1 Use of n-desulfated heparin for treating or preventing inflammations |
| 04/09/2003 | EP1300152A1 Percutaneous absorption type steroid preparation for external use |
| 04/09/2003 | EP1300151A2 Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension |
| 04/09/2003 | EP1300150A2 Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension |
| 04/09/2003 | EP1300149A2 Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension |
| 04/09/2003 | EP1300148A2 Use of bismuth subgallate in inhibition of production of nitric oxide synthase |
| 04/09/2003 | EP1300147A1 Purine compounds and adenosine A2 receptor antagonist as preventive or therapeutic agent for diabetes mellitus |
| 04/09/2003 | EP1300146A1 Pharmaceutical composition for the treatment of animal mammary tumors |
| 04/09/2003 | EP1300145A1 Therapeutic or preventive medicines for mood disorders or anxiety disorders |
| 04/09/2003 | EP1300144A2 Paroxetine in treatment of depression |
| 04/09/2003 | EP1300143A1 Patch containing 4-biphenylacetic acid |
| 04/09/2003 | EP1300142A1 Hypoglycemics |
| 04/09/2003 | EP1300141A1 Medical composition kit for treating lesioned abnormal tissue |
| 04/09/2003 | EP1300138A2 Agents effective against hyperreactive and hypoactive deficient skin conditions as well as manifest dermatitis |
| 04/09/2003 | EP1300084A2 Composition for the treatment of chronic venous insufficiencies comprising an extract of red vine leaves |
| 04/09/2003 | EP1299560A2 Identification and modulation of t helper-1 and t helper-2 cells |
| 04/09/2003 | EP1299529A2 Conserved diaphanous-related formin autoregulatory domain (dad) |
| 04/09/2003 | EP1299430A2 Process for preparing benzoxazin-4-one polymer conjugates |
| 04/09/2003 | EP1299424A1 COLD WATER SOLUBLE $g(b)-GLUCAN PRODUCT AND PROCESS FOR PREPARING THE SAME |
| 04/09/2003 | EP1299420A2 Composition for pharmaceutical and cosmetic products |
| 04/09/2003 | EP1299409A2 9.alpha.-chloro-6.alpha.-fluoro-17.alpha.-hydroxy-16-methyl-17-beta-methoxycarbonyl-androst-1,4-dienes esterified in position 17.alpha. by a cyclic acyl group |
| 04/09/2003 | EP1299400A1 Novel cytotoxic compounds and their use |
| 04/09/2003 | EP1299397A1 Novel cephalosporin compounds and process for preparing the same |
| 04/09/2003 | EP1299396A1 Novel cephalosporin compounds and process for preparing the same |
| 04/09/2003 | EP1299395A1 Oxazinoquinolones useful for the treatment of viral infections |
| 04/09/2003 | EP1299393A2 4-phenyl substituted tetrahydroisoquinolines and therapeutic use thereof |
| 04/09/2003 | EP1299392A2 Glucocortiocoid-selective antiinflammatory agents |
| 04/09/2003 | EP1299388A1 Variolin derivatives as anti-cancer agents |
| 04/09/2003 | EP1299387A1 Heterocycle carboxamides as antiviral agents |
| 04/09/2003 | EP1299386A1 Pyrroloquinolones as antiviral agents |
| 04/09/2003 | EP1299385A2 Fused cyclic modulators of nuclear hormone receptor function |
| 04/09/2003 | EP1299384A1 Indole derivatives useful for the treatment of cns disorders |
| 04/09/2003 | EP1299383A1 Sulfonyl-pyrrolidine derivatives useful for the treatment of neurological disorders |
| 04/09/2003 | EP1299382A1 Composition and antiviral activity of substituted indoleoxoacetic piperazine derivatives |
| 04/09/2003 | EP1299381A1 Substituted quinazoline derivatives and their use as inhibitors |
| 04/09/2003 | EP1299380A1 Indole derivatives useful for the treatment of cns disorders |
| 04/09/2003 | EP1299378A1 Tetrahydropyridino or piperidino heterocyclic derivatives |
| 04/09/2003 | EP1299377A2 Spla2 inhibitors |
| 04/09/2003 | EP1299376A1 Fatty acid synthase inhibitors |
| 04/09/2003 | EP1299374A1 Novel non-psychotropic cannabinoids |
| 04/09/2003 | EP1299373A1 Cyclic substituted aminomethyl compounds and medicaments containing said compounds |
| 04/09/2003 | EP1299372A1 Pyrones as inhibitors of cyclooxygenase-2 |
| 04/09/2003 | EP1299366A1 Method for producing a phenothiazine granulate with improved properties |